Sarepta Therapeutics (SRPT) EPS (Basic) (2010 - 2026)
Sarepta Therapeutics' (SRPT) quarterly EPS (Basic) came in at $3.15 in Q1 2026, up 168.59% year-on-year from $1.17 in Q1 2025, and up 211.58% quarter-over-quarter from -$2.83 in Q4 2025.
Sarepta Therapeutics (SRPT) EPS (Basic) (2010 - 2026) Analysis & Trends
Sarepta Therapeutics' EPS (Basic) history runs 17 years deep, the most recent figure standing at $3.15 for Q1 2026.
- On a quarterly basis, EPS (Basic) rose 168.59% year-over-year to $3.15 in Q1 2026; TTM through Mar 2026 was $0.62, a 124.31% increase from a year earlier, with the FY2025 full-year figure at -$7.13, down 387.99% from the prior year.
- EPS (Basic) improved to $3.15 in Q1 2026 per SRPT's latest filing, from -$2.83 in the prior quarter.
- Across five years, EPS (Basic) topped out at $3.76 in Q4 2022 and bottomed at -$1203.7 in Q1 2022.
- The 5-year median for EPS (Basic) is -$0.27 (2023), against an average of -$73.59.
- Across the five-year window, EPS (Basic) tumbled 57082.35% in 2022 and soared 2696.06% in 2025, its largest moves.
- Year by year, EPS (Basic) stood at $3.76 in 2022, then sank by 86.91% to $0.49 in 2023, then surged by 239.26% to $1.67 in 2024, then tumbled by 269.16% to -$2.83 in 2025, then soared by 211.58% to $3.15 in 2026.
- Per Business Quant, the three latest SRPT EPS (Basic) figures stand at $3.15 (Q1 2026), -$2.83 (Q4 2025), and -$1.8 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Sarepta Therapeutics | 1.66 Bn | 1.25 Bn | 622.04 Mn | 3.15 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.15 |
| Dec 31, 2025 | -2.83 |
| Sep 30, 2025 | -1.80 |
| Jun 30, 2025 | 2.01 |
| Mar 31, 2025 | -4.60 |
| Dec 31, 2024 | 1.67 |
| Sep 30, 2024 | 0.35 |
| Jun 30, 2024 | 0.07 |
| Mar 31, 2024 | 0.39 |
| Dec 31, 2023 | 0.49 |
| Sep 30, 2023 | -0.46 |
| Jun 30, 2023 | -0.27 |
| Mar 31, 2023 | -5.86 |
| Dec 31, 2022 | 3.76 |
| Sep 30, 2022 | -23.01 |
| Jun 30, 2022 | -20.49 |
| Mar 31, 2022 | -1,203.68 |
| Dec 31, 2021 | -1.50 |
| Sep 30, 2021 | -602.70 |
| Jun 30, 2021 | -1.02 |